Effient and Intraventricular haemorrhage - a phase IV clinical study of FDA data

Summary:

Intraventricular haemorrhage is reported as a side effect among people who take Effient (prasugrel hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Aspirin, and have Cerebral haemorrhage.

The phase IV clinical study analyzes which people have Intraventricular haemorrhage when taking Effient. It is created by eHealthMe based on reports of 9,155 people who have side effects when taking Effient from the FDA, and is updated regularly.

What is Effient?

Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.

What is Intraventricular haemorrhage?

Intraventricular haemorrhage (intraventricular bleeding) is found to be associated with 288 drugs and 381 conditions by eHealthMe. Check the latest studies of Intraventricular haemorrhage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

9,155 people reported to have side effects when taking Effient.
Among them, 12 people (0.13%) have Intraventricular haemorrhage.

Could Effient cause Intraventricular haemorrhage?

Among these 12 people:

How long have people been on Effient when they have Intraventricular haemorrhage? *

What is the gender of people who have Intraventricular haemorrhage when taking Effient? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Intraventricular haemorrhage when taking Effient? *

What are other drugs people take besides Effient? *

What are other side effects people have besides Intraventricular haemorrhage? *

Hydrocephalus (water on the brain): 6 people, 50.00%
Subarachnoid Haemorrhage (blood leaks into the space between two membranes that surround the brain): 5 people, 41.67%
Vith Nerve Paralysis: 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Pupil Fixed: 2 people, 16.67%
Vessel Perforation: 2 people, 16.67%
Basal Ganglia Haemorrhage (bleeding from blood vessels in an area of the brain responsible for body movements): 1 person, 8.33%
Brain Death: 1 person, 8.33%
Brain Stem Haemorrhage (bleeding into structures of brain stem): 1 person, 8.33%
Cerebral Haemorrhage (bleeding within the brain): 1 person, 8.33%

What are the existing conditions these people have? *

Cerebral Haemorrhage (bleeding within the brain): 2 people, 16.67%
Percutaneous Coronary Intervention: 1 person, 8.33%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 8.33%
Drug Dependence: 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
Acute Myocardial Infarction (acute heart attack): 1 person, 8.33%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Effient and have Intraventricular haemorrhage?

- Check whether Intraventricular haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Effient:

Effient (9,482 reports)

Browse all side effects of Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intraventricular haemorrhage:

Intraventricular haemorrhage (288 drugs)

Browse all the conditions that are associated with Intraventricular haemorrhage:

Intraventricular haemorrhage (381 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prasugrel hydrochloride (the active ingredients of Effient) and Effient (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.